RecruitingNot ApplicableNCT06774248

Expanding the Youth Opioid Recovery Support (YORS) Intervention for MOUD Adherence to Adolescents With OUD


Sponsor

Potomac Health Foundations

Enrollment

80 participants

Start Date

Feb 1, 2025

Study Type

INTERVENTIONAL

Summary

Despite rising rates of fatal opioid overdoses in the United States, adolescents with OUD are far less likely than adults to receive and be retained on medication for opioid use disorder (MOUD). The multicomponent Youth Opioid Recovery Support (YORS) intervention for young adults seeks to increase adherence to extended-release MOUD and reduce opioid relapse through family involvement, assertive outreach, low-barrier access to MOUD, and contingency management. By expanding investigations of the evidence based YORS intervention to adolescents, especially those on sublingual buprenorphine, this project will significantly contribute to our knowledge base of practical strategies to address the opioid crisis in youth.


Eligibility

Min Age: 13 YearsMax Age: 21 Years

Inclusion Criteria16

  • English speaking
  • Provision of signed and dated informed assent form (may be collected verbally over audio and/or video platform in the event of a remote enrollment)
  • Willing to have a legal, English-speaking guardian provide informed consent (may be collected verbally over audio and/or video platform in the event of a remote enrollment)
  • Stated willingness to comply with all study procedures and the YORS intervention
  • Age 13-21 (inclusive)
  • Documented diagnosis of opioid use disorder (OUD)
  • Presenting for an index episode of inpatient or outpatient treatment at Maryland Treatment Centers with at least one day of opioid use in the 30 days prior to enrollment
  • Considering treatment with XR-NTX, XR-BUP, or SL-BUP* OR has begun SL-BUP maintenance treatment within the past two weeks
  • Willing to designate a parent, family member, or other person to be involved in their OUD treatment as a Treatment Significant Other
  • Access to a mobile phone
  • English speaking
  • Provision of signed and dated informed consent form (may be collected verbally over audio and/or video platform in the event of a remote enrollment)
  • Stated willingness to comply with all study procedures and the YORS intervention
  • Parent, legal guardian, or other treatment support person designated by an adolescent patient participant to be involved in their OUD treatment as a Treatment Significant Other
  • Age 18 years or older
  • Access to a mobile phone

Exclusion Criteria3

  • Psychiatric or medical instability that, in the opinion of the PI, would preclude participation in the trial (e.g., suicidality, psychosis, Sickle Cell disease with frequent crises)
  • Living situation that, in the opinion of the PI, would preclude participation in the trial (e.g., location greater than 75 miles from the treatment center, homelessness)
  • \. Known to currently be sharing drugs with the adolescent participant

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALYouth Opioid Recovery Support (YORS)

The Youth Opioid Recovery Support (YORS) model is an innovative wrap-around approach that attempts to address barriers to medication adherence in this vulnerable young adult population. The YORS intervention primary components are (as detailed below): 1. Low barrier access to MOUD, including home delivery, ride-share app transportation and mobile van delivery and low barrier access to MOUD in general 2. Engagement of families in collaborative treatment planning and monitoring with a focus on medication adherence 3. Assertive continuing care: actively tracking and communicating with youth and families by text and social media to promote engagement and adherence 4. Contingency management: to provide incentives for medication adherence


Locations(1)

Maryland Treatment Centers

Baltimore, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06774248